TRIO General Research Brief: What End-Users Think About HIV Prevention Products and Multipurpose Prevention Technologies (MPT)
This factsheet features the main findings from the Tablets, Ring, Injections as Options study (TRIO), a multiphase study conducted with young women in Kenya and South Africa between 2015 and 2017 to understand their perspectives on future MPTs. TRIO identified anticipated enablers and barriers to adoption and use of future MPTs, explored preferred product characteristics, and solicited novel product design recommendations. The study was led by RTI International with support from the Bill & Melinda Gates Foundation.
January 2020
Click for full info +Full Info:
Resource Type:
Citation:
This factsheet features the main findings from the Tablets, Ring, Injections as Options study (TRIO), a multiphase study conducted with young women in Kenya and South Africa between 2015 and 2017 to understand their perspectives on future MPTs. TRIO identified anticipated enablers and barriers to adoption and use of future MPTs, explored preferred product characteristics, and solicited novel product design recommendations. The study was led by RTI International with support from the Bill & Melinda Gates Foundation.
Authors:
RTI International | Women’s Global Health Imperative
Health Risks(s):
- HIV
- Unintended Pregnancy
Product type(s):
- Contraceptives
- Hormonal
Topic(s):
Region(s)
- Africa